CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-29 | Duke Barry S See remarks | Grant or award | +978 | $10.31 | $10K | 5,891 |
| 2016-06-09 | Fallon John A. Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2016-06-09 | SANTINI GINO Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-06-09 | Nadav Eran Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-06-09 | Schroeder Theodore R Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-06-09 | BOHLIN GAREN G Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-06-09 | Freund John Gordon Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-06-09 | Hirsch David Director | Grant or award · Stock Option (Right to Purchase) | +8,700 | 8,700 | ||
| 2016-05-20 | Brannelly Paul Executive Vice President & CFO | Grant or award | +1,100 | $16.89 | $19K | 82,376 |
| 2016-05-18 | Brannelly Paul Executive Vice President & CFO | Grant or award | +900 | $16.00 | $14K | 81,276 |
| 2016-05-17 | Brannelly Paul Executive Vice President & CFO | Grant or award | +1,000 | $15.46 | $15K | 80,376 |
| 2016-05-16 | Brannelly Paul Executive Vice President & CFO | Grant or award | +800 | $15.73 | $13K | 79,376 |
| 2016-05-13 | Brannelly Paul Executive Vice President & CFO | Grant or award | +1,200 | $15.02 | $18K | 78,576 |
| 2016-04-05 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise | +9,673 | $3.31 | $32K | 383,117 |
| 2016-04-05 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise | +3,931 | $0.48 | $2K | 387,048 |
| 2016-04-05 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise · Stock Option (Right to Purchase) | −9,673 | 0 | ||
| 2016-04-05 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise · Stock Option (Right to Purchase) | −3,931 | 3,013 | ||
| 2016-01-22 | Schroeder Theodore R Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2016-01-20 | Duke Barry S See remarks | Grant or award | +4,913 | 4,913 | ||
| 2016-01-20 | Duke Barry S See remarks | Grant or award · Stock Option (Right to Purchase) | +29,475 | 29,475 |
Page 37 of 41 · 811 trades